Лучшие больницы для «Coronary Artery Angiography (CAG)» в Бангалор, Индия
10 больниц по направлению «Кардиоторакальная и сосудистая хирургия» представлены в нашей сети в Индия, Бангалор, с аккредитацией NABH, JCI, NABL, ISO 9001.
На этой странице перечислены больницы направления «Кардиоторакальная и сосудистая хирургия» (включая Coronary Artery Angiography (CAG)) в Бангалор, Индия, включая Narayana Health, Manipal Hospitals, Medicover Hospital, Bangalore, Gleneagles Hospitals, Bengaluru и другие.
Спросите нас о «Coronary Artery Angiography (CAG)» в Бангалор, Индия
Оставьте свои данные — наша команда координации свяжется с вами и расскажет о следующих шагах.
Сравните 10 аккредитованных больниц (Кардиоторакальная и сосудистая хирургия) в Бангалор, Индия
Рекомендуем🇮🇳 Narayana Health
Больница занимает 1-е место в этом списке по указанному рейтингу (4.8/5, 1750 отзывов).
🇮🇳 Manipal Hospitals
Больница занимает 2-е место в этом списке по указанному рейтингу (4.7/5, 1450 отзывов).
🇮🇳 Medicover Hospital, Bangalore
Больница занимает 3-е место в этом списке по указанному рейтингу (4.7/5, 68 отзывов).
🇮🇳 Gleneagles Hospitals, Bengaluru
Больница занимает 4-е место в этом списке по указанному рейтингу (4.7/5, 142 отзывов).
🇮🇳 Manipal Hospital Malleshwaram (Northside)
Больница занимает 5-е место в этом списке по указанному рейтингу (4.6/5, 71 отзывов).
🇮🇳 Manipal Hospital, Old Airport Road
Больница занимает 6-е место в этом списке по указанному рейтингу (4.5/5, 87 отзывов).
🇮🇳 Manipal Hospital Yeshwanthpur (Columbia Asia)
Больница занимает 7-е место в этом списке по указанному рейтингу (4.5/5, 98 отзывов).
🇮🇳 Manipal Hospital Millers Road (Vikram Hospital)
Больница занимает 8-е место в этом списке по указанному рейтингу (4.4/5, 74 отзывов).
🇮🇳 Apollo Hospital, Bannerghatta Road
Больница занимает 9-е место в этом списке по указанному рейтингу (4.2/5, 25 отзывов).
🇮🇳 Fortis Hospital, Bannerghatta Road
Больница занимает 10-е место в этом списке по указанному рейтингу (4.2/5, 58 отзывов).
Как мы выбираем эти больницы
Больница появляется на этой странице, если направление «Кардиоторакальная и сосудистая хирургия» указано среди её специализаций и она находится в Бангалор, Индия. Сортировка — по указанному рейтингу (по убыванию), без редакционного рейтинга «лучших».
Как выбрать лучшую больницу для «coronary artery angiography (cag)» в Бангалор, Индия?
Выбор подходящей больницы для «coronary artery angiography (cag)» — важное решение в вашем пути лечения. Вот на что стоит обратить внимание:
Международная аккредитация
Ищите больницу с международной аккредитацией, например JCI или NABH — см. отметки аккредитации у каждой больницы ниже.
Специализация
Убедитесь, что в больнице есть отделение, специализирующееся на «Кардиоторакальная и сосудистая хирургия», а не только общая помощь.
Мощность и опыт
Количество коек и год основания, указанные ниже, отражают масштаб и операционный опыт больницы.
Прозрачность стоимости
Запросите детализированную смету перед поездкой — используйте наш калькулятор стоимости для первичной оценки.
Что нужно знать о процедуре «Coronary Artery Angiography (CAG)»
Coronary Artery Angiography (CAG), also known as cardiac catheterization or coronary angiogram, is the gold-standard invasive imaging procedure used to visualize coronary artery anatomy, quantify stenosis severity, and guide decisions for percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG). The procedure carries a diagnostic accuracy exceeding 95% in experienced hands, with major complication rates below 0.5% at high-volume tertiary centers. GAF Healthcare connects international patients with JCI- and NABH-accredited hospitals in India and JCI- and DHA-licensed facilities in Dubai and Abu Dhabi, offering world-class interventional cardiology at a fraction of Western costs, with end-to-end logistics support from visa facilitation to post-procedure follow-up. Hospital Stay: 1–2 days (day-procedure or overnight observation) • Total Stay in Country (Fit-to-Fly): 3–5 days (short-haul); 5–7 days (long-haul international flight) • Success Rate: ≥ 95% diagnostic success rate; major complication rate < 0.5%
Clinical Overview
Coronary artery disease (CAD) results from the progressive accumulation of atherosclerotic plaques within the intimal layer of the epicardial coronary arteries. Over time, lipid-laden plaques trigger inflammatory cascades, fibrous cap formation, and varying degrees of luminal narrowing — quantified angiographically as percent diameter stenosis. Hemodynamically significant stenoses (typically ≥ 70% in non-left main vessels, or ≥ 50% in the left main coronary artery) reduce coronary flow reserve, precipitating myocardial ischemia under stress or, in the setting of acute plaque rupture, causing unstable angina or acute myocardial infarction (AMI). Non-invasive modalities such as stress echocardiography, myocardial perfusion SPECT, cardiac CT angiography (CCTA), and CMR can detect ischemia with reasonable sensitivity, but coronary artery angiography remains the anatomical reference standard that uniquely allows simultaneous therapeutic intervention. During CAG, a catheter is advanced under fluoroscopic guidance — most commonly via the radial artery (transradial approach) or, less frequently, the femoral artery (transfemoral approach) — to the ostia of the left and right coronary arteries. Iodinated contrast medium is injected while cine-fluoroscopic images are captured in multiple angulated projections, delineating lesion location, morphology (eccentric vs. concentric), calcification, thrombus burden, and collateral circulation. Advanced adjunctive technologies routinely integrated at GAF Healthcare partner hospitals include fractional flow reserve (FFR) and instantaneous wave-free ratio (iFR) for physiological lesion assessment, intravascular ultrasound (IVUS) for plaque characterization and stent optimization, and optical coherence tomography (OCT) for near-histological resolution of fibrous cap thickness — all of which profoundly influence revascularization decision-making beyond angiographic appearance alone. Contemporary CAG practice is guided by internationally validated risk stratification tools including the SYNTAX Score (to determine lesion complexity and guide PCI vs. CABG selection), the TIMI Risk Score, the GRACE Score (in acute coronary syndrome settings), and the EuroSCORE II. At GAF Healthcare partner institutions, board-certified interventional cardiologists with fellowship training at institutions such as AIIMS, Apollo, Medanta, Cleveland Clinic-affiliated centers in Abu Dhabi, and American Hospital Dubai perform CAG to international guideline standards (ACC/AHA and ESC), ensuring that diagnostic findings directly translate into evidence-based management pathways.
Who is a Candidate?
• ELIGIBILITY — CLINICAL INDICATIONS: • Stable angina pectoris with objective evidence of ischemia on non-invasive testing (stress ECG, stress echo, nuclear perfusion imaging, or cardiac MRI) • Acute Coronary Syndrome (ACS): Non-ST-elevation myocardial infarction (NSTEMI) with intermediate-to-high GRACE score, or ST-elevation myocardial infarction (STEMI) requiring primary PCI • Suspected left main or multivessel disease with a high pre-test probability of significant CAD • Pre-operative cardiac evaluation before major non-cardiac surgery in patients with known or high-risk CAD • Unexplained heart failure or new-onset left ventricular systolic dysfunction (EF < 40%) with possible ischemic etiology • Valvular heart disease requiring surgical correction in patients aged > 40 years or with cardiac risk factors (to exclude concomitant significant CAD before surgery) • Positive or equivocal cardiac CT angiography (CCTA) findings requiring anatomical confirmation and possible intervention • Survivors of sudden cardiac arrest without obvious non-ischemic cause • Coronary anomalies detected on CCTA requiring functional characterization • REQUIRED PRE-PROCEDURE DIAGNOSTICS: • Resting 12-lead ECG and 24–72-hour Holter monitor (where indicated) • 2D Transthoracic Echocardiography (2D-TTE/ECHO): Assessment of LV/RV function, wall motion abnormalities, valve morphology, and pericardial effusion • Serum cardiac biomarkers: High-sensitivity Troponin I or T (hs-cTnI/T), CK-MB, BNP/NT-proBNP • Complete Blood Count (CBC), Renal Function Tests (serum creatinine, eGFR — mandatory for contrast safety), Liver Function Tests, Coagulation profile (PT/INR, aPTT) • Fasting blood glucose and HbA1c (contrast risk and medication management) • Lipid panel (LDL-C, HDL-C, triglycerides) • Thyroid Function Tests (if iodinated contrast allergy protocol or amiodarone use) • Chest X-ray (PA view) • Non-invasive stress testing results (stress ECG, nuclear SPECT, stress echo, or cardiac MRI) if available • Cardiac CT Angiography (CCTA) report, if previously performed • Blood group and type-and-screen • CONTRAINDICATIONS (RELATIVE AND ABSOLUTE): • Severe uncorrected coagulopathy (INR > 2.5 without reversibility strategy) — relative; bridging anticoagulation may be required • Acute kidney injury or severe chronic kidney disease (eGFR < 30 mL/min/1.73 m²) — relative; require pre-hydration, nephroprotective protocols, and CO₂ angiography or ultra-low contrast volume techniques • Documented severe allergy to iodinated contrast media without adequate premedication (corticosteroid + antihistamine protocol) — relative • Uncontrolled severe hypertension (SBP > 200 mmHg) — relative; defer until hemodynamically stabilized • Decompensated congestive heart failure (hemodynamic instability) — relative; stabilize before elective CAG • Active systemic infection or sepsis — relative; treat infection first unless ACS mandates urgent CAG • Severe peripheral arterial disease precluding safe arterial access — alternative access sites (e.g., brachial, ulnar, or distal radial) may be used • Patient refusal of informed consent — absolute • Pregnancy: relative contraindication due to radiation exposure; urgent cases require lead shielding and risk-benefit assessment
Treatment Options & Approaches
STANDARD DIAGNOSTIC CORONARY ANGIOGRAPHY (CONVENTIONAL CAG): The foundational technique involves selective catheterization of the left and right coronary ostia via either the transradial or transfemoral approach, using 5F or 6F diagnostic catheters (Judkins, Amplatz, or universal-tip designs). Cine-fluoroscopic image acquisition in standardized orthogonal and angulated projections (RAO/LAO cranial/caudal views) generates the two-dimensional luminogram that defines lesion severity by percent diameter stenosis (DS%). This approach remains the procedural standard for elective and semi-urgent diagnostic workups globally. TRANSRADIAL vs. TRANSFEMORAL ACCESS: The transradial approach (TRA) is now the preferred default at all GAF Healthcare partner centers, supported by Level IA evidence from landmark trials (RIVAL, MATRIX). TRA reduces major access-site bleeding by 60–70%, eliminates the need for bed rest post-procedure (patients ambulate within 1–2 hours), shortens hospital stay to a single-day or overnight admission, and significantly reduces vascular complications compared to transfemoral access. The transfemoral approach remains available for cases with documented radial artery occlusion, severe forearm anatomy anomalies, or high-complexity ad-hoc PCI requiring large-bore access (7F–8F). ADJUNCTIVE PHYSIOLOGICAL AND IMAGING MODALITIES: • Fractional Flow Reserve (FFR): A pressure wire-derived ratio (coronary pressure distal to lesion / aortic pressure) measured during pharmacological hyperemia (adenosine infusion). FFR ≤ 0.80 indicates hemodynamically significant ischemia warranting revascularization. FFR-guided PCI has demonstrated superior outcomes over angiography-guided PCI in FAME and FAME-2 trials, reducing unnecessary stenting of non-flow-limiting lesions. • Instantaneous Wave-Free Ratio (iFR): A resting-state adenosine-free pressure ratio (threshold ≤ 0.89), clinically non-inferior to FFR (DEFINE-FLAIR, iFR-SWEDEHEART trials), with faster procedural workflow and avoidance of adenosine side effects. • Intravascular Ultrasound (IVUS): A 20–40 MHz rotational catheter providing cross-sectional, tomographic images of plaque burden, vessel remodeling, calcification depth, and minimum lumen area (MLA). IVUS-guided PCI is associated with lower rates of target vessel failure and stent thrombosis versus angiography-alone guidance (ULTIMATE, IVUS-XPL trials). • Optical Coherence Tomography (OCT): Near-infrared light-based intracoronary imaging with 10–15 µm axial resolution, enabling differentiation of plaque phenotype (fibrous, calcified, lipid-rich, TCFA), assessment of fibrous cap thickness, and superior stent deployment optimization including edge dissection and incomplete stent apposition detection. • Coronary CT Angiography (CCTA) — Pre-Procedural Planning: CCTA with fractional flow reserve derived from CT (FFRCT, HeartFlow®) may serve as a gatekeeper to invasive CAG, identifying patients who truly require catheterization (NXT, PLATFORM trials), reducing unnecessary procedures. COMBINED DIAGNOSTIC + THERAPEUTIC (AD-HOC PCI): When a hemodynamically significant lesion is confirmed at CAG, the interventional cardiologist — with patient consent obtained pre-procedure — may proceed directly to PCI using balloon angioplasty and drug-eluting stent (DES) implantation within the same session. Contemporary DES platforms (Resolute Onyx™, XIENCE™, Ultimaster Tansei™, Synergy™) feature biocompatible or biodegradable polymers eluting antiproliferative agents (zotarolimus, everolimus, biolimus) to minimize in-stent restenosis (ISR) rates to < 5–8% at 12 months. SPECIALIZED HIGH-COMPLEXITY TECHNIQUES (AVAILABLE AT GAF HEALTHCARE PARTNER CENTERS): • Rotational Atherectomy (Rotablator™): Burr-based plaque modification for heavily calcified, non-crossable lesions to enable adequate stent expansion. • Orbital Atherectomy (Diamondback 360®): Alternative calcium modification tool for severely calcified coronary lesions. • Intravascular Lithotripsy (Shockwave IVL, Shockwave Medical): Pulsatile ultrasonic energy delivered via a balloon catheter to fracture both intimal and medial calcium, facilitating stent delivery and expansion in calcified lesions. • Laser Coronary Angioplasty (ELCA): Excimer laser for thrombus-laden lesions, balloon-uncrossable lesions, and in-stent restenosis. • Chronic Total Occlusion (CTO) PCI: Advanced retrograde and antegrade wire escalation strategies (CART, Reverse CART) for complete coronary occlusions, performed by dedicated CTO operators with specialized training. • Left Main and Bifurcation PCI: Techniques including provisional single-stenting, T-stenting, TAP, Culotte, and double-kissing (DK) Crush, guided by IVUS/OCT for precise ostial coverage.
Восстановление
PRE-PROCEDURE PHASE (Days -7 to 0): Day -7 to -3 (Remote/Arrival): GAF Healthcare coordinates electronic transmission of all prior medical records, imaging (ECHO, stress test, CCTA), and laboratory results to the designated interventional cardiologist at the partner hospital. A tele-consultation is arranged for the patient to meet their cardiologist virtually, review findings, confirm the indication for CAG, discuss procedural risks and benefits, and obtain preliminary informed consent. Medication review is conducted: patients on anticoagulants (warfarin, NOACs) receive bridging or cessation instructions; metformin is typically withheld 48 hours before and after contrast exposure in patients with eGFR < 60 mL/min/1.73 m²; dual antiplatelet therapy (DAPT) instructions are issued based on clinical scenario. Day -1 to 0 (Hospital Admission / Pre-Op Assessment): Patient is admitted to the hospital (or attends a pre-admission clinic for day-procedure cases). Baseline investigations are repeated or verified: ECG, CBC, renal function, coagulation, blood glucose, blood group. An allergy history is formally documented; patients with prior contrast reactions receive premedication (methylprednisolone 32 mg orally at 12 and 2 hours pre-procedure + diphenhydramine 50 mg IV/IM 1 hour pre-procedure). Renal protection protocol (IV 0.9% NaCl hydration at 1 mL/kg/hr for 3–12 hours pre-procedure) is initiated for patients with eGFR 30–60 mL/min/1.73 m². The radial artery is assessed with a modified Allen's test and Barbeau test to confirm ulnar collateral patency before committing to transradial access. The patient is kept NPO for 4–6 hours before the procedure. PROCEDURE DAY: Pre-Procedure (1–2 hours before): IV access is established. Baseline vital signs, SpO₂, and peripheral pulses are documented. Informed consent is reconfirmed and signed. Pre-procedural medications are administered: antiplatelet loading (aspirin 300 mg + clopidogrel 600 mg or ticagrelor 180 mg loading dose, if ad-hoc PCI is anticipated), heparin or bivalirudin anticoagulation protocol is selected. The patient is transferred to the cardiac catheterization laboratory (Cath Lab). Intra-Procedure (30–90 minutes typical duration): 1. Patient is positioned on the fluoroscopy table; ECG monitoring, pulse oximetry, and blood pressure monitoring are attached. 2. The access site (typically right wrist for transradial) is sterilely prepped and draped. Local anesthetic (2% lidocaine) is infiltrated subcutaneously. 3. A 5F or 6F arterial sheath is placed using the Seldinger technique under fluoroscopic or ultrasound guidance. 4. A cocktail of vasodilators (verapamil 2.5–5 mg + nitroglycerin 100–200 µg) is administered intra-arterially to prevent radial artery spasm. 5. Diagnostic catheters (Judkins Left 3.5 or 4.0, Judkins Right 4.0, or universal catheters) are advanced to the coronary ostia under fluoroscopic guidance. 6. Iodinated contrast (iso-osmolar or low-osmolar, e.g., iodixanol or iopamidol) is injected while cine-fluoroscopic acquisitions are performed in multiple angulated projections. 7. Left ventriculography (LV-gram) may be performed to assess global and regional LV systolic function, identify wall motion abnormalities, and quantify the ejection fraction. 8. If FFR/iFR assessment is required, a pressure wire is advanced, and measurements are taken with or without adenosine infusion. 9. If IVUS or OCT is performed, the imaging catheter is advanced across the lesion and automated pullback images are acquired. 10. All images are reviewed in real time by the interventional cardiologist. The SYNTAX Score is calculated for multivessel disease. A Heart Team discussion may be initiated if CABG vs. PCI decision is non-straightforward. 11. If ad-hoc PCI is performed: balloon pre-dilation, stent selection and deployment, post-dilation with high-pressure non-compliant balloon, and final angiographic and physiological result assessment are completed. 12. The arterial sheath is removed (transradial: patent hemostasis band applied immediately, e.g., TR Band™; transfemoral: manual compression, closure device such as Angioseal™ or Perclose™, or compression band). POST-PROCEDURE RECOVERY PHASE: Hours 0–4 (Recovery Bay): Patient is monitored in the cardiac recovery area. Vital signs, ECG, and access site are checked every 15–30 minutes. Radial hemostasis band is progressively deflated per patent hemostasis protocol over 2 hours. The patient is encouraged to drink fluids to facilitate contrast excretion. Pain assessment is performed; analgesics are provided if needed. Hours 4–6: Patient ambulates (transradial cases); oral intake is resumed. Repeat renal function testing is ordered for high-risk CKD patients at 24–48 hours. Preliminary results discussion with the cardiologist occurs: the patient is counseled on findings, SYNTAX Score (if applicable), and recommended next steps (medical management, PCI, or CABG referral). Day 1 (Discharge): Most patients undergoing diagnostic-only CAG via transradial access are discharged the same day or after one overnight observation. A formal discharge summary, procedural report, and CD/images of angiography are provided to the patient. Medications are prescribed: DAPT (aspirin + clopidogrel/ticagrelor) if stenting was performed; antianginals, statins (high-intensity: atorvastatin 40–80 mg or rosuvastatin 20–40 mg), ACE inhibitor/ARB, and beta-blockers as indicated. Wound care instructions for the radial site are given. Day 2–5 (Post-Discharge Recovery): Patient recuperates at accommodation arranged by GAF Healthcare near the hospital. Radial access site is monitored for hematoma, swelling, or signs of radial artery occlusion. Light activities are permitted. Wrist-gripping activities and heavy lifting (> 2 kg) are restricted for 5–7 days. A virtual follow-up consultation with the cardiologist is arranged. Day 5–7 (Fit-to-Fly Assessment): The cardiologist formally assesses fitness for air travel. Criteria include: stable access site without active hematoma or vascular complication, hemodynamic stability, no arrhythmia requiring monitoring, no post-contrast renal dysfunction requiring ongoing IV management, and patient understanding of medication compliance. Medical summary and fitness-to-fly letter are issued by GAF Healthcare partner hospital for airline requirements.
Возможные риски
Coronary Artery Angiography is a low-risk procedure when performed by experienced interventional cardiologists at high-volume centers, but patients must be comprehensively informed of potential complications as part of the informed consent process. Major complications (occurring in < 0.5% of elective diagnostic cases at accredited centers) include: acute myocardial infarction (< 0.05%), stroke or transient ischemic attack (TIA) due to catheter-induced air or atheroembolism (< 0.07%), life-threatening arrhythmias including ventricular fibrillation (< 0.5%), arterial dissection at the access site or coronary ostium (rare, < 0.1%), and death (< 0.1% in elective cases). Access site complications, more common with transfemoral than transradial access, include hematoma, retroperitoneal bleeding, arteriovenous fistula, pseudoaneurysm, and acute radial artery occlusion (0.5–5% transradial, typically asymptomatic due to dual-hand circulation). Contrast-induced nephropathy (CIN), now termed contrast-associated acute kidney injury (CA-AKI), is a meaningful risk in patients with pre-existing CKD (eGFR < 60 mL/min/1.73 m²), diabetes mellitus, dehydration, or concurrent nephrotoxic drug use; it is mitigated by adequate pre- and post-procedural hydration, minimizing contrast volume (target < 3× eGFR mL), and using iso-osmolar contrast agents. Allergic and anaphylactoid reactions to iodinated contrast range from mild urticaria to life-threatening anaphylaxis (< 0.1%); prior reactions mandate premedication protocols. Radiation exposure during CAG is low (typically 2–10 mGy mean absorbed dose for diagnostic-only procedures) but is documented in the patient record and cumulative exposure is considered, particularly for younger patients or those requiring repeat procedures. Patients with diabetes on metformin must withhold the drug 48 hours post-contrast to avoid the rare risk of contrast-metformin associated lactic acidosis. Coronary artery perforation (< 0.1%), catheter-induced vasospasm (more common in young women with Prinzmetal angina physiology), and systemic infection from breach of sterile technique (extremely rare at accredited centers) complete the risk profile. GAF Healthcare partner hospitals maintain 24/7 cardiac surgery backup, emergency PCI capability, and intensive care infrastructure to manage any complication without delay.
Почему GAF Healthcare
GAF Healthcare provides comprehensive end-to-end non-medical support to ensure that every international patient's journey to India or the UAE is seamless, dignified, and stress-free from first inquiry to return home. VISA & ENTRY FACILITATION: • India: GAF Healthcare's dedicated visa coordination team assists patients in applying for the Indian e-Medical Visa (e-MV), available to citizens of over 170 countries. The e-MV allows a stay of up to 60 days per visit and is typically approved within 72 hours of application with hospital invitation letter support provided by GAF Healthcare. Accompanying attendants (spouses or family caregivers) apply simultaneously for the Indian e-Medical Attendant Visa. Both visas are processed online through the official Indian Government portal with our team providing document review and application guidance. • UAE (Dubai / Abu Dhabi): Citizens of GCC countries and over 50 nationalities including the EU, UK, USA, Australia, and Canada enjoy visa-free entry or visa-on-arrival access to the UAE for stays of 30–90 days, making it one of the most accessible medical tourism destinations globally. Patients from other nationalities requiring prior-entry visas receive full support from GAF Healthcare through our UAE partner hospitals' international patient services departments, which are authorized to issue official medical visa invitation letters. All UAE-based procedures are conducted at JCI-accredited and Dubai Health Authority (DHA) or Abu Dhabi Department of Health (DoH)-licensed facilities. AIRPORT TRANSFERS & GROUND LOGISTICS: GAF Healthcare arranges private, air-conditioned vehicle transfers between the international airport and the hospital or patient accommodation for both the patient and their attendant, at all hours of arrival. For patients with mobility limitations or requiring oxygen supplementation during ground transport, medically equipped ambulance transfers are coordinated in advance. DEDICATED PATIENT COORDINATORS & TRANSLATORS: Every GAF Healthcare patient is assigned a dedicated bilingual Patient Relationship Manager (PRM) who serves as a single point of contact throughout the entire journey — from pre-arrival documentation to discharge and return flight coordination. For non-English-speaking patients, certified medical interpreters fluent in Arabic, Russian, Uzbek, Swahili, French, Bengali, and other languages are available on-site or via secure video link at all consultations, procedural consents, and discharge briefings. ACCOMMODATION FOR PATIENTS AND ATTENDANTS: GAF Healthcare has negotiated preferred rates at partner hotels and serviced apartments located within 1–5 km of all partner hospitals, ranging from comfortable 3-star options to premium 5-star residences for patients seeking enhanced recovery environments. All accommodation options are vetted for accessibility (elevator access, accessible bathrooms), proximity to the hospital, and availability of in-room dietary services catering to cardiac-appropriate low-sodium, low-fat meal plans. For patients undergoing day-procedure CAG who do not require overnight hospital admission, accommodation serves as the primary recovery base with 24-hour GAF Healthcare coordinator on-call support. COMMUNICATION & CONTINUITY OF CARE: Following discharge, GAF Healthcare facilitates secure electronic transfer of the full procedural report, angiography imaging (DICOM CD), pathology results, and discharge medication summary to the patient's cardiologist in their home country. A structured 30-day remote follow-up is coordinated via GAF Healthcare's telemedicine platform, including a formal cardiology review at Day 7, Day 30, and at 3 months post-procedure, ensuring continuity between the treating hospital and the patient's home healthcare team.
Частые вопросы о процедуре «Coronary Artery Angiography (CAG)»
What is the cost of Coronary Artery Angiography (CAG) in India vs. the UAE?
How long do I need to stay in the country after Coronary Artery Angiography (CAG) before I am fit to fly home?
What is the success rate of Coronary Artery Angiography (CAG), and how experienced are the cardiologists at GAF Healthcare partner hospitals?
Как GAF Healthcare помогает выбрать лучшую больницу для «coronary artery angiography (cag)» в Бангалор, Индия
Найдите лучшие больницы для «coronary artery angiography (cag)» в Бангалор, Индия
На этой странице представлено 10 больниц в Бангалор, Индия, чтобы вы могли сравнить аккредитацию и специализации в одном месте.
Поддержка, когда она нужна
Отправьте нам свои медицинские отчёты в WhatsApp или по email — наша медицинская команда изучит их и предложит больницу и план лечения.
Прозрачные, всё включено цены
Мы предоставляем единую детализированную смету, покрывающую расходы больницы и проживание — без скрытых платежей.
Организация визы, поездки и проживания
После выбора больницы мы помогаем оформить визовое приглашение, забронировать проживание рядом с больницей и организовать трансфер.
Хотите узнать примерную стоимость лечения? Используйте наш калькулятор стоимости для персональной оценки.
Частые вопросы о «Coronary Artery Angiography (CAG)» в Бангалор, Индия
Сколько больниц направления «Кардиоторакальная и сосудистая хирургия» представлено в Бангалор, Индия?
Как вы выбираете больницы для списка?
Сколько стоит лечение в Бангалор, Индия?
Следующий шаг
Отправьте нам свои медицинские отчёты — наша команда предложит больницу и план лечения для «Coronary Artery Angiography (CAG)» в Бангалор, Индия.
Свяжитесь с нами, если заметите неточность на этой странице.